UFF
LLY icon

USA Financial Formulas’s Eli Lilly LLY Stock Holding History

USA Financial Formulas’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,165
Closed -$1.05M – 328
2024
Q2 		$1.05M Sell
1,165
-180
-13% -$144K 0.17% 60
2024
Q1 		$1.05M Buy
1,345
+1,335
+13,350% +$950K 0.17% 61
2023
Q4 		$5.83K Sell
10
-246
-96% -$144K ﹤0.01% 259
2023
Q3 		$138K Buy
256
+253
+8,433% +$130K 0.21% 115
2023
Q2 		$1.41K Sell
3
-63
-95% -$26.4K ﹤0.01% 345
2023
Q1 		$22.7K Buy
+66
New +$22.3K 0.04% 148
2022
Q3 		$1.2M Buy
3,699
+3,696
+123,200% +$1.17M 1.88% 18
2022
Q2 		$1K Hold
3
– – ﹤0.01% 280
2022
Q1 		$1K Sell
3
-17
-85% -$4.38K ﹤0.01% 313
2021
Q4 		$6K Sell
20
-190
-90% -$48.2K 0.01% 211
2021
Q3 		$49K Sell
210
-75
-26% -$18.5K 0.04% 207
2021
Q2 		$65K Sell
285
-96
-25% -$19.3K 0.05% 182
2021
Q1 		$71K Buy
381
+378
+12,600% +$73.9K 0.06% 188
2020
Q4 		$1K Sell
3
-7,745
-100% -$1.16M ﹤0.01% 287
2020
Q3 		$1.15M Sell
7,748
-6,294
-45% -$974K 0.87% 41
2020
Q2 		$2.31M Buy
14,042
+14,039
+467,967% +$2.15M 1.71% 18
2020
Q1 		$0 Hold
3
– – ﹤0.01% 278
2019
Q4 		$0 Hold
3
– – ﹤0.01% 276
2019
Q3 		$0 Buy
+3
New +$334 ﹤0.01% 240
2015
Q4 		– Sell
-49,880
Closed -$4.17M – 113
2015
Q3 		$4.17M Buy
+49,880
New +$4.21M 2.71% 10
2015
Q2 		– Sell
-38,063
Closed -$2.77M – 246
2015
Q1 		$2.77M Sell
38,063
-3,970
-9% -$283K 0.9% 29
2014
Q4 		$2.9M Buy
+42,033
New +$2.84M 1% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

USA Financial Formulas's LLY Position: Q3 2024 in Review

USA Financial Formulas sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 1,165 shares — an estimated $1.05M sold.

USA Financial Formulas first reported a position in LLY in Q4 2014 and held it in 22 quarters. The position peaked at $4.17M in Q3 2015. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • USA Financial Formulas reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
  • USA Financial Formulas sold 1,165 Eli Lilly shares in Q3 2024, an estimated $1.05M.
  • USA Financial Formulas first reported a position in Eli Lilly in Q4 2014 and held it in 22 quarters.
  • USA Financial Formulas's Eli Lilly position peaked at $4.17M in Q3 2015.
  • 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on USA Financial Formulas's 13F filing for Q3 2024, filed 8 Oct 2024.